Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02564198
Title A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

Advanced Solid Tumor

central nervous system cancer

Therapies

Ramucirumab

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.